Essential Pharma, an international generic pharmaceutical company dedicated to supplying well-established, “at risk” products to patients across multiple therapeutic areas, announces the appointment of Ben Ash as Chief Financial Officer.
Ben, who will lead Essential Pharma’s finance function, brings more than 17 years of finance experience to the company, 10 of which were in the pharmaceutical industry.
Ben joins the Company from PTC Therapeutics, a pharmaceutical company focused on rare diseases, where he was Vice President of Finance. Prior to this, Ben was Head of Finance, CEE & MEA at Shire. He also held various finance roles at Qinetiq, Smiths Medical and KPMG.
Ben Ash said:
“Essential Pharma has a strong track record of ensuring patients continue to have access to the medicines they need. I am excited to join this patient focused team as the company is executing on its growth strategy and building on its strong foundations. As Essential Pharma expands both its product portfolio and international reach via the acquisition of more at-risk products from leading pharma companies around the globe, I am looking forward to playing an important role in taking the company to the next level.”